BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26580235)

  • 1. Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity.
    Goldstone AP; Miras AD; Scholtz S; Jackson S; Neff KJ; Pénicaud L; Geoghegan J; Chhina N; Durighel G; Bell JD; Meillon S; le Roux CW
    J Clin Endocrinol Metab; 2016 Feb; 101(2):599-609. PubMed ID: 26580235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.
    Scholtz S; Miras AD; Chhina N; Prechtl CG; Sleeth ML; Daud NM; Ismail NA; Durighel G; Ahmed AR; Olbers T; Vincent RP; Alaghband-Zadeh J; Ghatei MA; Waldman AD; Frost GS; Bell JD; le Roux CW; Goldstone AP
    Gut; 2014 Jun; 63(6):891-902. PubMed ID: 23964100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of satiety gut hormones increases appetitive behavior after curative esophagectomy for esophageal cancer.
    Elliott JA; Docherty NG; Haag J; Eckhardt HG; Ravi N; Reynolds JV; le Roux CW
    Am J Clin Nutr; 2019 Feb; 109(2):335-344. PubMed ID: 30722001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
    Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
    Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.
    Borg CM; le Roux CW; Ghatei MA; Bloom SR; Patel AG; Aylwin SJ
    Br J Surg; 2006 Feb; 93(2):210-5. PubMed ID: 16392104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity surgery and neural correlates of human eating behaviour: A systematic review of functional MRI studies.
    Alabdulkader S; Al-Alsheikh AS; Miras AD; Goldstone AP
    Neuroimage Clin; 2024; 41():103563. PubMed ID: 38237270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Regional Brain Responses to Food Ingestion After Roux-en-Y Gastric Bypass and the Role of Gut Peptides: A Neuroimaging Study.
    Hunt KF; Dunn JT; le Roux CW; Reed LJ; Marsden PK; Patel AG; Amiel SA
    Diabetes Care; 2016 Oct; 39(10):1787-95. PubMed ID: 27660120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
    Murphy CF; Stratford N; Docherty NG; Moran B; Elliott JA; Healy ML; McMorrow JP; Ravi N; Goldstone AP; Reynolds JV; le Roux CW
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e204-e216. PubMed ID: 33000149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes.
    Halliday TM; Polsky S; Schoen JA; Legget KT; Tregellas JR; Williamson KM; Cornier MA
    Physiol Rep; 2019 Apr; 7(7):e14048. PubMed ID: 30927343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satiety and gastrointestinal hormones during a Mixed Meal Tolerance Test after gastric bypass surgery: association with plasma amino acid concentrations.
    van den Broek M; de Heide LJM; Emous M; Wijma RB; Veeger NJGM; Wolthuis A; Laskewitz AJ; Heiner-Fokkema MR; Muller Kobold AC; Wolffenbuttel BHR; van Beek AP
    Surg Obes Relat Dis; 2018 Aug; 14(8):1106-1117. PubMed ID: 29937240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuro-Endo-Microbio-Ome Study: A Pilot Study of Neurobiological Alterations Pre- Versus Post-Bariatric Surgery.
    Agarwal K; Maki KA; Vizioli C; Carnell S; Goodman E; Hurley M; Harris C; Colwell R; Steele K; Joseph PV
    Biol Res Nurs; 2022 Jul; 24(3):362-378. PubMed ID: 35426747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neural responsivity to food cues in relation to food preferences, but not appetite-related hormone concentrations after RYGB-surgery.
    Zoon HFA; de Bruijn SEM; Smeets PAM; de Graaf C; Janssen IMC; Schijns W; Aarts EO; Jager G; Boesveldt S
    Behav Brain Res; 2018 Nov; 353():194-202. PubMed ID: 30041007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled study.
    Behary P; Alessimii H; Miras AD; Tharakan G; Alexiadou K; Aldhwayan MM; Purkayastha S; Moorthy K; Ahmed AR; Bloom SR; Tan TM
    Diabetes Obes Metab; 2023 Jun; 25(6):1731-1739. PubMed ID: 36811311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass.
    de Hollanda A; Casals G; Delgado S; Jiménez A; Viaplana J; Lacy AM; Vidal J
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4677-84. PubMed ID: 26505823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
    Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
    Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.
    Valderas JP; Irribarra V; Boza C; de la Cruz R; Liberona Y; Acosta AM; Yolito M; Maiz A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1069-75. PubMed ID: 20097707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered neural inhibition responses to food cues after Roux-en-Y Gastric Bypass.
    Zoon HFA; de Bruijn SEM; Jager G; Smeets PAM; de Graaf C; Janssen IMC; Schijns W; Deden L; Boesveldt S
    Biol Psychol; 2018 Sep; 137():34-41. PubMed ID: 29944963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.